These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9550944)

  • 21. Glucocorticoids and behavioral effects of psychostimulants. II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels.
    Deroche V; Marinelli M; Le Moal M; Piazza PV
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1401-7. PubMed ID: 9190876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heroin self-administration by rats: influence of dose and physical dependence.
    Dai S; Corrigall WA; Coen KM; Kalant H
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1009-15. PubMed ID: 2798525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in the self-administration of cannabinoids and other drugs of abuse.
    Fattore L; Fadda P; Fratta W
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S227-36. PubMed ID: 19744795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Roman high- and low-avoidance rat lines differ in the acquisition, maintenance, extinction, and reinstatement of intravenous cocaine self-administration.
    Fattore L; Piras G; Corda MG; Giorgi O
    Neuropsychopharmacology; 2009 Apr; 34(5):1091-101. PubMed ID: 18418365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of social stress in addiction to psychostimulants: what we know from animal models.
    Aguilar MA; García-Pardo MP; Montagud-Romero S; Miñarro J; Do Couto BR
    Curr Pharm Des; 2013; 19(40):7009-25. PubMed ID: 23574439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse model of relapse to the abuse of drugs: procedural considerations and characterizations.
    Yan Y; Nabeshima T
    Behav Brain Res; 2009 Jan; 196(1):1-10. PubMed ID: 18782591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of juvenile chronic stress on adult cortico-accumbal function: Implications for cognition and addiction.
    Watt MJ; Weber MA; Davies SR; Forster GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):136-154. PubMed ID: 28642080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress, dysregulation of drug reward pathways, and the transition to drug dependence.
    Koob G; Kreek MJ
    Am J Psychiatry; 2007 Aug; 164(8):1149-59. PubMed ID: 17671276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug dependence: stress and dysregulation of brain reward pathways.
    Kreek MJ; Koob GF
    Drug Alcohol Depend; 1998; 51(1-2):23-47. PubMed ID: 9716928
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of oxytocin in the neuroadaptation to drugs of abuse.
    Sarnyai Z; Kovács GL
    Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress, habits, and drug addiction: a psychoneuroendocrinological perspective.
    Schwabe L; Dickinson A; Wolf OT
    Exp Clin Psychopharmacol; 2011 Feb; 19(1):53-63. PubMed ID: 21341923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between reinforcing properties and sensory/motor toxicity of CNS depressants; implications for the assessment of abuse liability.
    Brady JV; Lukas SE; Hienz RD
    NIDA Res Monogr; 1983 Apr; 43():196-202. PubMed ID: 6410252
    [No Abstract]   [Full Text] [Related]  

  • 34. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors.
    Piazza PV; Deroche V; Deminière JM; Maccari S; Le Moal M; Simon H
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11738-42. PubMed ID: 8265619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical characterization of individual vulnerability to addictive drugs in rats.
    Lucas LR; Angulo JA; Le Moal M; McEwen BS; Piazza PV
    Eur J Neurosci; 1998 Oct; 10(10):3153-63. PubMed ID: 9786209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in the vulnerability to drug abuse: a review of preclinical studies.
    Roth ME; Cosgrove KP; Carroll ME
    Neurosci Biobehav Rev; 2004 Oct; 28(6):533-46. PubMed ID: 15527861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats.
    Sutton MA; Karanian DA; Self DW
    Neuropsychopharmacology; 2000 Jun; 22(6):626-41. PubMed ID: 10788762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emotional valence and context of social influences on drug abuse-related behavior in animal models of social stress and prosocial interaction.
    Neisewander JL; Peartree NA; Pentkowski NS
    Psychopharmacology (Berl); 2012 Nov; 224(1):33-56. PubMed ID: 22955569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where is the locus in opioid withdrawal?
    Christie MJ; Williams JT; Osborne PB; Bellchambers CE
    Trends Pharmacol Sci; 1997 Apr; 18(4):134-40. PubMed ID: 9149542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.